420
Participants
Start Date
May 29, 2019
Primary Completion Date
June 30, 2027
Study Completion Date
October 21, 2027
Tislelizumab
200 mg administered Intravenously (IV) as specified in the treatment arm
Placebo
Tislelizumab placebo to match
Cisplatin
70 mg/m2 administered IV as specified in the treatment arm
Gemcitabine Hydrochloride
1000 mg/m2 administered IV as specified in the treatment arm
Carboplatin
Area Under the Curve (AUC) 4.5 administered IV as specified in the treatment arm
COMPLETED
Keelung Chang Gung Memorial Hospital and Loves Lake Branch, Anle Dist
COMPLETED
National Cheng Kung University Hospital, North Dist
COMPLETED
Taipei Veterans General Hospital, Beitou Dist
COMPLETED
Linkou Chang Gung Memorial Hospital, Guishan Dist
ACTIVE_NOT_RECRUITING
Peking University Third Hospital, Beijing
RECRUITING
Peking University First Hospital, Beijing
RECRUITING
Beijing Friendship Hospital, Capital Medical University, Beijing
RECRUITING
Fifth Medical Center of Pla General Hospital, Beijing
RECRUITING
Beijing Cancer Hospital, Beijing
COMPLETED
National Taiwan University Hospital, Zhongzheng Dist
COMPLETED
Peking Union Medical College Hospital, Beijing
COMPLETED
Chinese Pla General Hospital, Beijing
ACTIVE_NOT_RECRUITING
Liaoning Cancer Hospital and Institute, Shenyang
RECRUITING
The First Hospital of Jilin University, Changchun
ACTIVE_NOT_RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
ACTIVE_NOT_RECRUITING
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
ACTIVE_NOT_RECRUITING
Affiliated Zhongshan Hospital of Fudan University, Shanghai
COMPLETED
Huadong Hospital Affiliated to Fudan University, Shanghai
COMPLETED
Huashan Hospital Affiliated to Fudan University, Shanghai
COMPLETED
Shanghai Changhai Hospital, Shanghai
ACTIVE_NOT_RECRUITING
Jiangsu Province Cancer Hospital, Nanjing
RECRUITING
Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School, Nanjing
ACTIVE_NOT_RECRUITING
Anhui Provincial Hospital, Hefei
RECRUITING
The Second Affiliated Hospital of Tianjin Medical University, Tianjin
RECRUITING
Zhejiang Provincial Peoples Hospital, Hangzhou
COMPLETED
Zhejiang Cancer Hospital, Hangzhou
COMPLETED
Ningbo First Hospital, Ningbo
RECRUITING
The First Provincial Wenzhou Hospital of Zhejiang, Wenzhou
ACTIVE_NOT_RECRUITING
The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang
RECRUITING
The First Affiliated Hospital of Fujian Medical University, Fuzhou
RECRUITING
The First Affiliated Hospital of Xiamen University, Xiamen
RECRUITING
The Second Affiliated Hospital of Fujian Medical University, Quanzhou
RECRUITING
Chongqing Cancer Hospital, Chongqing
RECRUITING
Southwest Hospital, Chongqing
COMPLETED
Xiangya Hospital of Central South University, Changsha
RECRUITING
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
ACTIVE_NOT_RECRUITING
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan
ACTIVE_NOT_RECRUITING
Hubei Cancer Hospital, Wuhan
RECRUITING
Zhujiang Hospital of Southern Medical University, Guangzhou
RECRUITING
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou
RECRUITING
West China Hospital, Sichuan University, Chengdu
ACTIVE_NOT_RECRUITING
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu
ACTIVE_NOT_RECRUITING
Yunnan Cancer Hospital, Kunming
RECRUITING
The Second Affiliated Hospital of Xian Jiaotong University, Xi'an
RECRUITING
Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi
Lead Sponsor
BeiGene
INDUSTRY